1.12
price down icon3.03%   -0.035
after-market Handel nachbörslich: 1.11 -0.01 -0.89%
loading
Schlusskurs vom Vortag:
$1.155
Offen:
$1.12
24-Stunden-Volumen:
274.96K
Relative Volume:
0.59
Marktkapitalisierung:
$37.45M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-37.65M
KGV:
-0.7943
EPS:
-1.41
Netto-Cashflow:
$-24.14M
1W Leistung:
-1.75%
1M Leistung:
-22.22%
6M Leistung:
-63.40%
1J Leistung:
-76.12%
1-Tages-Spanne:
Value
$1.07
$1.145
1-Wochen-Bereich:
Value
$1.07
$1.22
52-Wochen-Spanne:
Value
$0.60
$6.3001

Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile

Name
Firmenname
Reviva Pharmaceuticals Holdings Inc
Name
Telefon
(408) 501-8881
Name
Adresse
10080 N WOLFE ROAD, CUPERTINO
Name
Mitarbeiter
15
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
RVPH's Discussions on Twitter

Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2022-01-24 Eingeleitet H.C. Wainwright Buy

Reviva Pharmaceuticals Holdings Inc Aktie (RVPH) Neueste Nachrichten

pulisher
08:47 AM

Reviva to Participate in the UBS Global Healthcare Conference - GlobeNewswire

08:47 AM
pulisher
Oct 18, 2024

Reviva To Report Long-Term Safety Data For Brilaroxazine In Schizophrenia: Will The Stock Recover? - RTTNews

Oct 18, 2024
pulisher
Oct 09, 2024

Schizophrenia Clinical Trial Pipeline Insights Featuring 55+ Companies | DelveInsight - GlobeNewswire Inc.

Oct 09, 2024
pulisher
Oct 08, 2024

Reviva to Participate in the 2024 Maxim Healthcare Virtual Summit - The Manila Times

Oct 08, 2024
pulisher
Oct 07, 2024

Reviva Pharmaceuticals Schizophrenia Drug Demonstrates Strong Efficacy On Heels Of Bristol Myers, FDA Approval: Analyst - Benzinga

Oct 07, 2024
pulisher
Oct 02, 2024

Reviva to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - GlobeNewswire

Oct 02, 2024
pulisher
Sep 26, 2024

Reviva Pharmaceuticals to Participate in the Lytham Partners Fall 2024 Investor Conference - The Manila Times

Sep 26, 2024
pulisher
Sep 23, 2024

CA Pharma Co. Reports Positive Phase 3 Data for Schizophrenia Treatment - Streetwise Reports

Sep 23, 2024
pulisher
Sep 18, 2024

RVPH’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle

Sep 18, 2024
pulisher
Sep 18, 2024

Market Momentum: Reviva Pharmaceuticals Holdings Inc. (RVPH) Registers a 9.40 Increase, Closing at 1.28 - The Dwinnex

Sep 18, 2024
pulisher
Sep 16, 2024

RVPH: RECOVER Biomarker KOL Event - Yahoo Finance

Sep 16, 2024
pulisher
Sep 13, 2024

Closing Strong: Reviva Pharmaceuticals Holdings Inc. (RVPH) Ends at 1.12, Down -13.85 from Last Close - The Dwinnex

Sep 13, 2024
pulisher
Sep 10, 2024

A stock that deserves closer examination: Reviva Pharmaceuticals Holdings Inc. (RVPH) - US Post News

Sep 10, 2024
pulisher
Sep 09, 2024

Reviva reports positive schizophrenia trial results - Investing.com India

Sep 09, 2024
pulisher
Sep 09, 2024

Reviva Announces New Vocal Biomarker Data from Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia - GlobeNewswire

Sep 09, 2024
pulisher
Sep 04, 2024

How to interpret Reviva Pharmaceuticals Holdings Inc. (RVPH)’s stock chart patterns - US Post News

Sep 04, 2024
pulisher
Sep 04, 2024

Reviva Pharmaceuticals Holdings Inc. (RVPH) Stock: A Year of Stock Market Dynamics - The InvestChronicle

Sep 04, 2024
pulisher
Sep 04, 2024

Reviva to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire

Sep 04, 2024
pulisher
Aug 30, 2024

RVPH’s Stock Market Adventure: -79.42% YTD Growth Amidst Volatility - The InvestChronicle

Aug 30, 2024
pulisher
Aug 27, 2024

Reviva to Host Virtual KOL Event to Discuss Vocal Biomarker - GlobeNewswire

Aug 27, 2024
pulisher
Aug 27, 2024

Reviva to Host Virtual KOL Event to Discuss Vocal Biomarker Data from Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia on September 4, 2024 - StockTitan

Aug 27, 2024
pulisher
Aug 26, 2024

RVPH: August OLE Update - Yahoo Finance

Aug 26, 2024
pulisher
Aug 21, 2024

Reviva Pharmaceuticals Launches Multi-Million Share Offering - TipRanks

Aug 21, 2024
pulisher
Aug 21, 2024

Reviva Pharmaceuticals Holdings Inc. (NASDAQ: RVPH) Drops -25.71% In Early Trade; What Lies Ahead? - Stocks Register

Aug 21, 2024
pulisher
Aug 21, 2024

Reviva Pharmaceuticals Holdings Inc. [RVPH] stock Initiated by ROTH MKM analyst, price target now $12 - The DBT News

Aug 21, 2024
pulisher
Aug 21, 2024

Check Out Reviva Pharmaceuticals Holdings Inc. (RVPH)’s Trade Data Rather Than the Analysts’ Views - SETE News

Aug 21, 2024
pulisher
Aug 21, 2024

Reviva Pharmaceuticals Announces Pricing of $5.0 Million - GlobeNewswire

Aug 21, 2024
pulisher
Aug 21, 2024

Reviva Pharmaceuticals Announces Pricing of $5.0 Million Underwritten Offering Priced At-the-Market Under Nasdaq Rules - Marketscreener.com

Aug 21, 2024
pulisher
Aug 20, 2024

A closer look at Reviva Pharmaceuticals Holdings Inc. (RVPH) is warranted - US Post News

Aug 20, 2024
pulisher
Aug 19, 2024

Reviva Pharmaceuticals Holdings Inc.’s Shares Reel: -62.34% Quarterly Revenue Decline Amid 19.20M Market Cap - The InvestChronicle

Aug 19, 2024
pulisher
Aug 19, 2024

Ratios Reveal: Breaking Down Reviva Pharmaceuticals Holdings Inc. (RVPH)’s Financial Health - The Dwinnex

Aug 19, 2024
pulisher
Aug 19, 2024

Vanguard Group Inc. Purchases 26,854 Shares of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) - Defense World

Aug 19, 2024
pulisher
Aug 16, 2024

Reviva Pharmaceuticals (NASDAQ:RVPH) Stock Rating Reaffirmed by Maxim Group - Defense World

Aug 16, 2024
pulisher
Aug 16, 2024

Maxim Group Downgrades Reviva Pharmaceuticals Holdings (RVPH) - MSN

Aug 16, 2024
pulisher
Aug 14, 2024

Reviva Pharmaceuticals Holdings Inc. Inc. (RVPH) Price Performance Over the Years: A Comparative Study - The InvestChronicle

Aug 14, 2024
pulisher
Aug 14, 2024

Reviva Reports Second Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire

Aug 14, 2024
pulisher
Aug 14, 2024

Balance Sheet Insights: Reviva Pharmaceuticals Holdings Inc. (RVPH)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Aug 14, 2024
pulisher
Aug 14, 2024

RVPH stock touches 52-week low at $0.76 amid market challenges - Investing.com

Aug 14, 2024
pulisher
Aug 07, 2024

Market Momentum: Reviva Pharmaceuticals Holdings Inc. (RVPH) Registers a -4.80 Decrease, Closing at 0.90 - The Dwinnex

Aug 07, 2024
pulisher
Aug 06, 2024

Reviva secures US patent for lung disease treatment By Investing.com - Investing.com Canada

Aug 06, 2024
pulisher
Aug 06, 2024

Reviva secures US patent for lung disease treatment - Investing.com

Aug 06, 2024
pulisher
Aug 06, 2024

Reviva Announces Grant of U.S. Patent Covering Use of - GlobeNewswire

Aug 06, 2024
pulisher
Aug 06, 2024

Reviva Announces Grant of U.S. Patent Covering Use of Brilaroxazine for the Treatment of Idiopathic Pulmonary Fibrosis - Yahoo Finance

Aug 06, 2024
pulisher
Aug 05, 2024

RVPH Stock Plummets to 52-Week Low at $0.94 Amid Market Struggles - Investing.com

Aug 05, 2024
pulisher
Aug 02, 2024

Reviva Pharmaceuticals (NASDAQ:RVPH) Stock Price Down 8.5% - Defense World

Aug 02, 2024
pulisher
Jul 25, 2024

RVPH’s Stochastic Averages Dip: Analyzing Reviva Pharmaceuticals Holdings Inc.’s Stock Performance - The InvestChronicle

Jul 25, 2024
pulisher
Jul 25, 2024

Reviva Pharmaceuticals Holdings Inc. (RVPH)’s stock price range in the last year - US Post News

Jul 25, 2024
pulisher
Jul 24, 2024

Closing Figures Unveiled: Reviva Pharmaceuticals Holdings Inc. (RVPH) Gain 7.07, Closes at 1.05 - The Dwinnex

Jul 24, 2024
pulisher
Jul 13, 2024

Certain Common Stock of Reviva Pharmaceuticals Holdings, Inc. are subject to a Lock-Up Agreement Ending on 14-JUL-2024. - Marketscreener.com

Jul 13, 2024
pulisher
Jul 11, 2024

HC Wainwright Reaffirms “Buy” Rating for Reviva Pharmaceuticals (NASDAQ:RVPH) - Defense World

Jul 11, 2024

Finanzdaten der Reviva Pharmaceuticals Holdings Inc-Aktie (RVPH)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$22.32
price down icon 1.11%
$74.12
price up icon 0.26%
$373.97
price up icon 3.48%
$54.36
price down icon 0.66%
$202.64
price down icon 1.63%
$113.10
price down icon 0.74%
Kapitalisierung:     |  Volumen (24h):